| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 30 | 23 | 30 | 36 | 40 | 51 | 73 | 0 |
| Expenses | 30 | 22 | 27 | 28 | 32 | 41 | 60 | 0 |
| EBITDA | 0 | 0 | 3 | 8 | 9 | 10 | 13 | 0 |
| Operating Profit % | 1 % | 1 % | 10 % | 22 % | 21 % | 20 % | 17 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 3 | 7 | 8 | 10 | 12 | 0 |
| Tax | 0 | 0 | 1 | 2 | 2 | 2 | 3 | 0 |
| Net Profit | 0 | 0 | 2 | 5 | 6 | 7 | 9 | 0 |
| EPS in ₹ | 1.77 | 0.88 | 42.54 | 6.72 | 5.36 | 6.26 | 6.57 | 0.00 |
Shelter Pharma
Shelter Pharma
30.81
+0.19
(0.62%)
Market Cap
51.82 Cr
PE Ratio
5.71
Volume
9,000.00
Day High - Low
30.81 - 30.80
52W High-Low
46.88 - 23.00
Key Fundamentals
Market Cap
51.82 Cr
EPS
6.57
PE Ratio
5.71
PB Ratio
0.71
Book Value
43.16
EBITDA
12.72
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
16.94
Debt to Equity
0.02
Actual
Company News
View All News
Shelter Pharma's board approved Vinita Gadhavi as independent director and Parvezbanu Idariya for re-appointment. The 19th AGM is scheduled for September 29, 2026.
Shelter Pharma received a significant export order worth Rs 1.17 crore from Taha Drugs & Chemicals Co. Ltd for nutraceuticals to Sudan. This adds to recent wins from the same client.
Shelter Pharma disclosed a significant export order worth Rs 1.44 crore from Taha Drugs & Chemicals Co. Ltd for supply of Nutraceutical Tablets to Sudan, adding to its recent order book.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,840.00 | #1 4,41,477.63 | 36.91 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 34.00 | |
9,322.00 | 2,47,469.81 | 85.36 | 11,067.00 | 13.95 | 2,568 | 65.50 | 63.65 | |
4,965.50 | 1,88,871.66 | 86.95 | 13,886.20 | 20.34 | 2,138 | 3.28 | 52.16 | |
1,119.10 | 1,12,607.65 | 24.28 | 27,657.90 | 17.64 | 5,026 | -34.90 | 45.64 | |
1,366.00 | 1,10,351.67 | 33.22 | 29,044.60 | 2.24 | 3,870 | -39.18 | 35.27 | |
1,969.00 | 1,06,297.76 | 95.94 | 6,867.80 | 22.01 | 890 | #1 123.93 | 68.28 | |
1,165.50 | 97,280.68 | 29.91 | 35,058.60 | 3.90 | 4,158 | -69.10 | 47.72 | |
1,679.80 | 96,651.98 | 25.88 | 34,145.20 | 5.56 | 3,503 | 25.21 | 57.04 | |
2,095.00 | 95,790.22 | #1 17.09 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 28.17 | |
2,280.00 | 94,163.08 | 44.87 | 14,636.40 | 14.85 | 1,938 | 29.13 | 37.57 |
Growth Rate
Revenue Growth
44.24 %
Net Income Growth
25.69 %
Cash Flow Change
379.59 %
ROE
-2.14 %
ROCE
-1.88 %
EBITDA Margin (Avg.)
-12.53 %
Yearly Financial Results
Order Value Trend
FY 2026-27 order value₹2,76,506.69 Cr
FY 2026-2712 Orders
Taha Drugs & Chemicals Co. Ltd
88.66%First Veterinary Medicines Tra...
6.62%Genet International
4.44%Verka Dairy Ludhiana
0.18%Al-Saqr Agro for Agricultural ...
0.10%Others
0.00%Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 11 | 10 | 13 | 21 | 38 | 48 | 84 |
| Fixed Assets | 2 | 2 | 2 | 2 | 4 | 6 | 7 |
| Current Assets | 8 | 8 | 10 | 19 | 30 | 33 | 55 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 24 |
| Other Assets | 9 | 9 | 11 | 20 | 34 | 42 | 0 |
| Total Equity & Liabilities | 11 | 10 | 13 | 21 | 38 | 48 | 84 |
| Current Liabilities | 4 | 3 | 4 | 6 | 2 | 5 | 7 |
| Non Current Liabilities | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Total Equity | 7 | 7 | 9 | 15 | 36 | 43 | 73 |
| Reserve & Surplus | 7 | 7 | 8 | 7 | 24 | 31 | 56 |
| Share Capital | 1 | 1 | 1 | 8 | 12 | 12 | 17 |
Cash Flow
| Cash Flow | 2017 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 5 | -2 |
| Investing Activities | 0 | 0 | 0 | -1 | 0 | -4 | -7 |
| Operating Activities | 0 | -0 | -0 | 1 | 0 | -2 | 6 |
| Financing Activities | 0 | 0 | 1 | 0 | 0 | 11 | 0 |
Share Holding
| % Holding | Aug 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Aug 2025 | Sept 2025 | Oct 2025 | Nov 2025 | Mar 2026 | May 2026 |
| Promoter | 56.89 % | 56.89 % | 56.89 % | 54.97 % | 52.32 % | 52.32 % | 52.32 % | 46.98 % | 47.19 % | 44.38 % | 44.38 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.22 % | 30.18 % | 30.23 % | 40.12 % | 43.24 % | 42.69 % | 42.82 % | 48.66 % | 49.32 % | 51.46 % | 51.46 % |
| Others | 13.89 % | 12.93 % | 12.88 % | 4.91 % | 4.44 % | 4.99 % | 4.86 % | 4.36 % | 3.49 % | 4.16 % | 4.16 % |
| No of Share Holders | 1,165 | 836 | 868 | 1,119 | 1,153 | 1,109 | 1,094 | 1,094 | 1,093 | 1,071 | 1,076 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Sept 2026 |  Annual General Meeting | NA | 29 Sept 2026 | 31.50 | 30.81 |
| 23 Sept 2024 |  Dividend | ₹ 0.33 /share | 23 Sept 2024 | 46.97 | 48.21 |
| 30 Sept 2024 | Annual General Meeting | NA | 30 Sept 2024 | 46.97 | 47.50 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 46.88 | 47.15 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 38.00 | 39.50 |
| 23 Jul 2025 |  Extraordinary General Meeting | NA | 23 Jul 2025 | 39.60 | 43.97 |
| 23 Sept 2025 | Dividend | ₹ 0.35 /share | 23 Sept 2025 | 45.00 | 43.27 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 45.00 | 44.00 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 41.50 | 41.86 |
| 28 May 2026 | Quarterly Result Announcement | NA | 28 May 2026 | 31.00 | 30.00 |
Announcements
Newspaper Advertisement - Notice To The Members Of The Company Regarding 19Th Annual General Meeting To Be Held At The Registered Office Of The Company On Tuesday 29Th September 2026
7 days ago
7 days agoNotice Of AGM - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20159 days ago
9 days agoReg. 34 (1) Annual Report.9 days ago
9 days agoIntimation Of The Cut-Off Date For The AGM Of The Company "Shelter Pharma Limited"Sep 01, 2026
Sep 01, 2026Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2026
Sep 01, 2026Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday 01ST September 2026 At 01.45 PM.Sep 01, 2026
Sep 01, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export OrderAug 25, 2026
Aug 25, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export OrderAug 24, 2026
Aug 24, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - New Product Launch.Aug 21, 2026
Aug 21, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015
Completion And Commencement Of Dispatch Of Export OrderAug 20, 2026
Aug 20, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Commencement Of Dispatch Of Export OrderAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateJul 31, 2026
Jul 31, 2026Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On 31St July 2026Jul 31, 2026
Jul 31, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 27, 2026
Jul 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 24, 2026
Jul 24, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2026
Jul 14, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 10, 2026
Jul 10, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Successful Dispatch Of Export Order.Jul 01, 2026
Jul 01, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 27, 2026
Jun 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 20, 2026
Jun 20, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJun 17, 2026
Jun 17, 2026Corrigendum To Intimation Of H2 FY2026 Investor Conference CallJun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 15, 2026
Jun 15, 2026Corrigendum To Intimation Of H2 FY2026 Investor Conference Call Withdrawal Of Scheduled MeetingJun 08, 2026
Jun 08, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Commencement Of Dispatch Of Export OrderJun 08, 2026
Jun 08, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 05, 2026
Jun 05, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Receipt Of Good Manufacturing Practices CertificateJun 03, 2026
Jun 03, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015-Receipt Of Renewal Manufacturing LicenceJun 02, 2026
Jun 02, 2026Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2026
May 28, 2026Outcome Of The Board Meeting And Submission Of The
Audited Standalone Financial Results For The Half Year And
Year Ended March 31 2026May 28, 2026
May 28, 2026Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And
Year Ended March 31 2026.May 28, 2026
May 28, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May 2026May 22, 2026
May 22, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015-Continuous Positive Customer Feedback On Company ProductsMay 19, 2026
May 19, 2026Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 International Pharmaceutical ExihibitionMay 18, 2026
May 18, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
Receipt Work Order Pursuant To Tender Process.May 15, 2026
May 15, 2026Intimation Under Regulation 30 For Successfully Conducted A CME Programme In Patna Bihar On 11Th May 2026May 13, 2026
May 13, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015- New Product Launch.May 11, 2026
May 11, 2026Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMay 05, 2026
May 05, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday May 05 2026 For Conversion Of 111000 Warrants Into 111000 Equity Shares Of Face Value Of Rs. 10/-May 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMay 01, 2026
May 01, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday May 01 2026.May 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 29, 2026
Apr 29, 2026Intimation Under Regulation 30 Update On Export OperationApr 16, 2026
Apr 16, 2026Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion PlansApr 15, 2026
Apr 15, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclousure Requirements ) Regulation 2015 For Hiring Of Senior Management Personnel In Line With Business Expansion PlansApr 07, 2026
Apr 07, 2026Technical Indicators
RSI(14)
Neutral 52.92
ATR(14)
Less Volatile 1.29
STOCH(9,6)
Oversold 14.61
STOCH RSI(14)
Oversold 2.82
MACD(12,26)
Bearish -0.24
ADX(14)
Weak Trend 23.42
UO(9)
Bearish 32.96
ROC(12)
Downtrend And Accelerating -5.43
WillR(14)
Neutral -73.27
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
